Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL536462 | 0.89 | LMNA (0.48) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL14849495 | 0.83 | LMNA (0.50) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL6290111 | 0.81 | LMNA (0.48) | LMNATDP1TSHRCYP3A4ATM | |
| SCHEMBL28457088 | 0.81 | LMNA (0.48) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL6704359 | 0.81 | MAPT (0.34) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL536468 | 0.81 | LMNA (0.44) | LMNATDP1TSHRCA2CHRM1 | |
| SCHEMBL3863847 | 0.80 | LMNA (0.47) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL10650540 | 0.80 | LMNA (0.47) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL10650550 | 0.80 | LMNA (0.47) | LMNAMAPTTDP1TSHRCYP3A4 | |
| SCHEMBL6283806 | 0.79 | LMNA (0.46) | LMNATDP1TSHRCYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4894406-A | 2-ALKYL-1,3-HEXANEDIOL ALKYL ESTERS | EASTMAN KODAK COMPANY (US) | 1990-01-16 | — | — | US | claimed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | disclosed |
| US-11292935-B2 | Composition for encapsulation and containment of substances | Tru BLOC LLC (US) | 2022-04-05 | — | — | US | disclosed |
| CN-113167695-A | Device for collecting volatile organic compounds | 法国由内政部代表 | 2021-07-23 | — | — | CN | disclosed |
| US-20200385603-A1 | Composition for Encapsulation and Containment of Substances | Tru BLOC LLC (US) | 2020-12-10 | — | — | US | disclosed |
| US-10752800-B2 | Composition for encapsulation and containment of substances | Tru BLOC LLC (US) | 2020-08-25 | — | — | US | disclosed |
| US-20190055424-A1 | Composition for Encapsulation and Containment of Substances | Tru BLOC LLC (US) | 2019-02-21 | — | — | US | disclosed |
| WO-2019036248-A1 | COMPOSITION FOR ENCAPSULATION AND CONTAINMENT OF SUBSTANCES | Tru BLOC LLC (US) | 2019-02-21 | — | — | WO | disclosed |
| US-20040202955-A1 | an offset lithographic printing master by imagewise application of droplets of a coalescing agent on an imageable layer comprising hydrophobic polymer particles precoated on a hydrophilic lithographic base; a developer removes the noncoalesced areas | KODAK GRAPHIC COMMUNICATIONS CANADA COMPANY (CA) | 2004-10-14 | — | — | US | disclosed |
| US-4894406-A | 2-ALKYL-1,3-HEXANEDIOL ALKYL ESTERS | EASTMAN KODAK COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | BCL2, BAX, EPCAM | LMNA 1718/4885MAPT 3088/4885TDP1 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.